We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+5.26%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$24B
AUM Growth
+$1.05B
Cap. Flow
-$221M
Cap. Flow %
-0.92%
Top 10 Hldgs %
13.73%
Holding
1,494
New
103
Increased
612
Reduced
406
Closed
115

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$114M
2
AET
Aetna Inc
AET
+$96.3M
3
TRV icon
Travelers Companies
TRV
+$94.5M
4
CHK
Chesapeake Energy Corporation
CHK
+$89M
5
AEE icon
Ameren
AEE
+$69.4M

Top Sells

Rank Stock Value
1
DB icon
Deutsche Bank
DB
+$247M
2
VZ icon
Verizon
VZ
+$186M
3
MDT icon
Medtronic
MDT
+$150M
4
LO
LORILLARD INC COM STK
LO
+$126M
5
JCI icon
Johnson Controls International
JCI
+$104M

Sector Composition

Rank Sector Weight
1 Healthcare 15.44%
2 Technology 14.68%
3 Financials 12.75%
4 Industrials 11.1%
5 Energy 9.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SSRI
351
DELISTED
Silver Standard Resources
SSRI
$12.5M 0.05%
1,437,628
+17,200
+1% +$149K
EMR icon
352
Emerson Electric
EMR
$82B
$12.4M 0.05%
187,297
+57,186
+44% +$3.84M
RAI
353
DELISTED
Reynolds American Inc
RAI
$12.3M 0.05%
408,784
-1,061,976
-72% -$30.5M
AIG icon
354
American International
AIG
$39.7B
$12.2M 0.05%
223,787
+42,228
+23% +$2.24M
TGNA
355
DELISTED
TEGNA Inc
TGNA
$12.2M 0.05%
742,616
+64,016
+9% +$938K
EPP icon
356
iShares MSCI Pacific ex Japan ETF
EPP
$2.25B
$12.1M 0.05%
245,704
-5,300
-2% -$263K
SRE icon
357
Sempra
SRE
$53.1B
$12.1M 0.05%
230,848
+65,088
+39% +$3.23M
CBST
358
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
$12M 0.05%
172,257
-6,985
-4% -$475K
CBD
359
DELISTED
Companhia Brasileira de Distribuicao
CBD
$12M 0.05%
259,114
+2,711
+1% +$127K
CNK icon
360
Cinemark Holdings
CNK
$3.93B
$12M 0.05%
338,289
-573,344
-63% -$17.5M
APC
361
DELISTED
Anadarko Petroleum
APC
$11.9M 0.05%
108,667
+7,861
+8% +$800K
SGEN
362
DELISTED
Seagen Inc. Common Stock
SGEN
$11.9M 0.05%
310,397
+20,216
+7% +$764K
BDX icon
363
Becton Dickinson
BDX
$50.6B
$11.8M 0.05%
101,916
+26,405
+35% +$2.99M
ITUB icon
364
Itaú Unibanco
ITUB
$91B
$11.7M 0.05%
2,034,650
+133,120
+7% +$784K
CIB icon
365
Grupo Cibest SA
CIB
$23.8B
$11.6M 0.05%
201,219
-91,144
-31% -$5.18M
STT icon
366
State Street
STT
$50.9B
$11.4M 0.05%
170,150
-55,294
-25% -$3.64M
TFCFA
367
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$11.4M 0.05%
323,649
+71,238
+28% +$2.42M
VTRS icon
368
Viatris
VTRS
$19.1B
$11.4M 0.05%
220,580
-1,191,790
-84% -$58.6M
AVY icon
369
Avery Dennison
AVY
$13B
$11.3M 0.05%
221,400
-21,800
-9% -$1.08M
MEOH icon
370
Methanex
MEOH
$4.99B
$11.1M 0.05%
179,300
+19,600
+12% +$1.2M
CSGP icon
371
CoStar Group
CSGP
$12.8B
$11.1M 0.05%
699,200
+332,000
+90% +$5.38M
YUM icon
372
Yum! Brands
YUM
$38.4B
$11.1M 0.05%
189,439
+38,702
+26% +$2.15M
B
373
Barrick Mining
B
$70.3B
$11.1M 0.05%
602,412
-13,574
-2% -$235K
SSYS icon
374
Stratasys
SSYS
$659M
$10.9M 0.05%
96,064
-46,500
-33% -$4.56M
IRWD icon
375
Ironwood Pharmaceuticals
IRWD
$671M
$10.9M 0.05%
848,848
-23,063
-3% -$251K
13 14
15
16 17

Similar funds

VI
Ventas Inc Chicago, Illinois $91.9M AUM 27.96% 1-Year Est. Return
FA
Forefront Analytics West Conshohocken, Pennsylvania $92M AUM 25.18% 1-Year Est. Return
PBCM
Point Break Capital Management Miami, Florida $91.7M AUM
CCAM
Crystal Cove Asset Management Newport Beach, California $91.7M AUM
GBA
Garrison Bradford & Associates New York $92.2M AUM 19.08% 1-Year Est. Return
AWP
Atlas Wealth Partners Wyomissing, Pennsylvania $91.6M AUM 9.52% 1-Year Est. Return
HI
Hyundai Investments Yeongdeungopo-Gu, Seoul, South Korea $92.3M AUM 0.12% 1-Year Est. Return
DCA
DB&C Advisors Holland, Michigan $92.4M AUM

Axa's Q2 2014 Portfolio in Review

As of Q2 2014, Axa held 1,494 positions worth $24B, up 4.6% from $23B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Axa's Q2 2014 filing shows 103 new, 612 increased, 406 reduced and 115 closed positions. Its largest new stake was Boston Scientific: 4,394,250 shares worth $56.1M. The largest sale was Deutsche Bank, an estimated $247M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Technology and Financials.

  • Axa's largest Q2 2014 buy was Boston Scientific: 4,394,250 shares worth $56.1M.
  • Axa added most to Gilead Sciences in Q2 2014, an estimated $114M increase.
  • Axa's biggest Q2 2014 reduction was Deutsche Bank, cutting an estimated $247M.
  • Axa fully exited OMNICARE INC in Q2 2014, selling an estimated $20.4M.
  • Axa's ten largest holdings make up 14% of its $24B portfolio in Q2 2014.
  • Axa opened 103 new positions and closed 115 in Q2 2014.
  • Axa's portfolio value rose 4.6% quarter-over-quarter to $24B.

Based on Axa's 13F filing for Q2 2014, filed 13 Aug 2014.